Results 121 to 130 of about 92,350 (272)
Implementation and use of risk minimization control tools in the EU: A multistakeholder survey
Aims This study characterized stakeholders' experiences with national implementation of risk minimization control tools (RMCTs), such as healthcare professional qualification, healthcare facility accreditation and medical intervention prior to treatment initiation, for eight medicinal products across eight European Union countries. Methods We conducted
Sharon C. M. Essink +21 more
wiley +1 more source
Aims Almost 5% of pregnancies are affected by immune‐mediated inflammatory diseases (IMIDs). As treatments become available, understanding their use during pregnancy is important. We aimed to describe maternal, pregnancy and infant outcomes among IMID pregnancies exposed to biologic therapies. Methods Using the Merative™ MarketScan® Commercial Database,
Leah K. Flatman +3 more
wiley +1 more source
Tackling cancer stemness with nanotechnology in the era of precision medicine
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo +9 more
wiley +1 more source
Abstract CD19‐directed CAR‐T cell therapy has become the standard of care for the treatment of relapsed/refractory LBCL, MCL, FL and BCP‐ALL. Expansion of CAR‐T cells in the peripheral blood (PB) of patients in the first weeks after infusion is an important biomarker for the prediction of therapy response and occurrence of toxicities.
Gerulf Hänel +16 more
wiley +1 more source
Efektivitas Terapi Tocilizumab Terhadap Mortalitas Pasien COVID-19 Derajat Berat di Rumah Sakit “X” Surabaya: studi observasional [PDF]
Tocilizumab merupakan agen inhibitor IL-6 yang direkomendasikan untuk terapi pasien COVID-19 derajat berat hingga kritis. Beberapa penelitian menunjukan hasil yang bervariasi terkait waktu pemberian tocilizumab yang optimal.
Djunaidy, Vania Denise +4 more
core +1 more source
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher +12 more
wiley +1 more source
Longitudinal serum and CSF cytokine dynamics in NORSE: Associations with immunotherapy exposure
Abstract Objective To characterize serum and cerebrospinal fluid (CSF) cytokine dynamics according to immunotherapy exposure in cryptogenic new‐onset refractory status epilepticus (cNORSE). Methods We analyzed cytokine profiles in 94 serum and 42 CSF samples from 29 and 14 patients, respectively, with cNORSE.
Aurélie Hanin +29 more
wiley +1 more source
Can Ultrasound Guide Treatment Decisions in Difficult‐to‐Treat Rheumatoid Arthritis?
Arthritis &Rheumatology, EarlyView.
Danila Madonna +7 more
wiley +1 more source
Calcitonin gene‐related peptide (CGRP) in epilepsy: Mechanistic insights from preclinical models
Abstract Calcitonin gene‐related peptide (CGRP) is a pleiotropic neuropeptide widely expressed in the central and peripheral nervous systems, with established roles in neurovascular regulation, synaptic transmission, and neuroinflammation. While CGRP has been extensively characterized in migraine pathophysiology, its role in epilepsy remains ...
Marina Romozzi +8 more
wiley +1 more source
A Pilot Study on Tocilizumab in Very-Late-Onset Myasthenia Gravis
Ting-Ting Yang,1,* Ze-Yi Wang,1,* Ze-Xin Fan,1 Bo-Yi Yuan,1 Lin Ma,1 Jian-Feng Lu,1 Pen-Ju Liu,1 Yang He,2 Guang-Zhi Liu1 1Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People’s Republic of China ...
Yang TT +8 more
core

